VALTREX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Valacyclovir Hydrochloride.
| Product ID | 55289-926_7bbcacd0-85df-18b0-e053-2a91aa0a7fc1 |
| NDC | 55289-926 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VALTREX |
| Generic Name | Valacyclovir Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1995-08-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020487 |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | VALACYCLOVIR HYDROCHLORIDE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2011-12-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-16 |
| Marketing End Date | 2019-09-12 |
| Marketing Category | NDA |
| Application Number | NDA020487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-16 |
| Marketing End Date | 2019-09-12 |
| Marketing Category | NDA |
| Application Number | NDA020487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-16 |
| Marketing End Date | 2019-09-12 |
| Marketing Category | NDA |
| Application Number | NDA020487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-16 |
| Marketing End Date | 2019-09-12 |
| Marketing Category | NDA |
| Application Number | NDA020487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-16 |
| Marketing End Date | 2019-09-12 |
| Marketing Category | NDA |
| Application Number | NDA020487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-16 |
| Marketing End Date | 2019-09-12 |
| Ingredient | Strength |
|---|---|
| VALACYCLOVIR HYDROCHLORIDE | 500 mg/1 |
| SPL SET ID: | d8028584-4186-41d6-b74b-2535971aa216 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0173-0565 | VALTREX | valacyclovir hydrochloride |
| 0173-0933 | VALTREX | valacyclovir hydrochloride |
| 50090-0753 | VALTREX | VALTREX |
| 55289-926 | VALTREX | VALTREX |
| 63629-3982 | VALTREX | VALTREX |
| 70518-2039 | VALTREX | VALTREX |
| 67296-0200 | VALTREX | VALTREX |
| 0378-4275 | Valacyclovir Hydrochloride | valacyclovir hydrochloride |
| 0378-4276 | Valacyclovir Hydrochloride | valacyclovir hydrochloride |
| 0781-5208 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
| 0781-5209 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
| 0904-6565 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
| 10544-937 | valacyclovir hydrochloride | valacyclovir hydrochloride |
| 16714-697 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
| 16714-698 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
| 21695-832 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
| 21695-965 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
| 43063-200 | Valacyclovir Hydrochloride | Valacyclovir Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VALTREX 74643955 2053301 Live/Registered |
GLAXOSMITHKLINE LLC 1995-03-09 |
![]() VALTREX 74423957 1879098 Live/Registered |
GLAXOSMITHKLINE LLC 1993-08-12 |
![]() VALTREX 74138827 not registered Dead/Abandoned |
CHEVRON CHEMICAL COMPANY 1991-02-13 |